Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis

BACKGROUND: Autologous mesenchymal stem cell neurotrophic factor–secreting cells (NurOwn(®)) have the potential to modify underlying disease mechanisms in progressive multiple sclerosis (PMS). OBJECTIVE: This open-label phase II study was conducted to evaluate safety/efficacy of three intrathecal ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jeffrey A, Lublin, Fred D, Lock, Christoper, Pelletier, Daniel, Chitnis, Tanuja, Mehra, Munish, Gothelf, Yael, Aricha, Revital, Lindborg, Stacy, Lebovits, Chaim, Levy, Yossef, Motamed Khorasani, Afsaneh, Kern, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896300/
https://www.ncbi.nlm.nih.gov/pubmed/36113170
http://dx.doi.org/10.1177/13524585221122156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896300/
https://www.ncbi.nlm.nih.gov/pubmed/36113170
http://dx.doi.org/10.1177/13524585221122156

Ejemplares similares